WALTHAM, Mass., April 2, 2015 – Alere Inc. (NYSE: ALR), a global leader in rapid diagnostic tests, today announced that its Alere™ i Strep A test has received marketing clearance from the U.S. Food ...
Alere Inc ALR recently announced 510(k) approval from the U.S. Food and Drug Administration (FDA) for its Alere i RSV test, a unified solution of rapid and accurate diagnosis of RSV diseases. Notably, ...
(Reuters) - Alere Inc said it initiated a voluntary recall of certain blood clot test strips in the United States following reports of nine serious adverse events that included bleeding related to the ...
BOSTON (Reuters) - Alere Inc has agreed to pay $33.2 million to resolve claims it knowingly sold unreliable diagnostic testing devices to hospitals prior to its acquisition by Abbott Laboratories last ...
Pune, Maharashtra, India, January 19 2021 (Wiredrelease) MarketResearch.Biz –:An extensive and elaborate primary research on Global Drug Screening Market report sheds light on numerous facets such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback